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However, only poor data are known about safety and efficacy of diltiazem in this setting.
The aim of our study was to evaluate the safety and efficacy of different vasodilators in the
prevention of RAS during transradial PCI.
Methods: 332 patients were consecutively randomized to blindly receive diltiazem 5 mg
(n 117), verapamil 2.5 mg (n109), or isosorbide dinitrate 1 mg (n 106) in three
centers (Paris, France). All study drugs were administrated through the arterial sheath. The
primary end point was the occurrence of a severe RAS defined by the operator as severe
limitation of the catheter movement, with or without angiographic confirmation. Second-
ary endpoints included minor RAS, safety events (need for vasopressor, fluids, atropine
support) and pain assessment scale.
Results: Main characteristics including age, sex, weight, height, diabetes, arterial sheath
diameters, and number of coronary catheters used were identical across the three groups. The
rate of severe RAS was lowest in patients receiving isosorbide dinitrate (n4, 3.8%), and
verapamil (n6, 5.5%), compared to diltiazem (n12, 10.3%) but the difference was not
statistically significant (p0.128). The same results were found for minor RAS, respectively
17.4%, 16.0% and 25.6% (p0.147). There was also no significant difference in term of safety
events and pain sensation between the different groups. PCI was successful for all patients and
no switch to transfemoral was reported in the entire population.
Conclusions: Frequency of severe RAS tended to be higher in patients receiving
diltiazem compared to verapamil and isosorbide dinitrate during transradial procedures.
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Left and Right Heart Catheterizations Utilizing the Radial Artery and
Forearm Vein: a Single Center Experience
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Background: The transradial approach for left heart catheterization has become more
frequent due to lower rate of major access site complications Even if the central venous
access from periferal veins is an established technique, less data are available with regard
to its use in the right heart catheterization.
Methods: We analyzed data on 764 patients who underwent left and right heart
catheterizations in our hospital between January 2009 and March 2012.From January
2010 all 4 operators of the Cath-Lab have chosen the radial artery as a standardized
approach for left catheterization and the forearm vein for the right catheterization.
Procedural information, need of access shift, vascular complications, radiological data,
duration of the procedure, type and amount of contrast agent were recorded.
Results: On this population, left and right heart catheterization utilizing the radial artery and
superficial forearm vein were been completed in 325 on 764 patients (45%). 302 (43%)
patients underwent left and right catheterization trough the leg, 106 pts underwent left heart
catheterization through the radial artery and right catheterization trough the femoral vein, 31 pts
underwent left catheterization trough femoral artery and right catheterization trough forearm
vein. From January 2011 the 82% of patients underwent complete cardiac catheterization
trough radial artery and forearm vein. The vein shift from forearm to femoral vein occurred in
14 patients (4%) and the arterial shift from radial to femoral approach in 21 patients (6%). In
the group of right heart catheterization utilizing the superficial forearm vein, complications
related to the vein acces occurred in 1 patients (artero-venouse fistula); in the group of artery
radial access site complications occurred in 2 patients (one artery perforation and one
succlavian artery dissection): no case required surgical treatment.
Conclusions: The transradial artery and superficial forearm venous approach for bilateral
cardiac catheterizations can be safe and feasible alternative to the femoral approach. This
approach can improve safety and patient comfort. Learn and take confidence with this
venous technique can improve the operator’s r.
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Background: Percutaneous approach techniques with closure device after transcutane-
ous aortic valve implantation (TAVI), have diminished vascular complications, which
nevertheless still occur. In this retrospective study we will report incidence and
angiographic factors predisposing to major vascular complications, in patients undergoing
TAVI using Prostar® XL closure device as a default strategy.
Methods: Consecutive patients, who underwent TAVI transfemorally using Prostar® XL,
were evaluated. The incidence of vc was evaluated according to VARC criteria. Using arterial
angiography, the femoral-iliac arterial tortuosity was adjusted for large arterial diameters, and
expressed as the ratio Total Tortuosity/Arterial Diameter (TT/AD). Arterial calcification, the
combination of angulation and atheromatosis at the puncture site, and ideal puncture, were
evaluated too. In all patients, 30 days follow-up was available.
Results: Out of 112 patients treated with TAVI, in 84 patients (42 males (48.8%),
80.25.86 years, AVA: 0.650.14 cm2) the procedure was performed transfemorally. In
patients with major vascular complications (17/84 (20.23%)) comparing to those without,
arterial calcification (11 pts (64.7%) vs. 8 pts (11.9%), p0.01) and the TT/AD (30.2 
11.25 vs. 22.06  8.64, p0.01) were independent predictors. A correlation of the
angiographic TT with the one calculated with computed tomography in 10 selected
patients was verified (r0.66, p0.013). Additionally, ideal puncture was achieved more
frequently among patients without vascular complications comparing to those with major
(94.1% vs. 70.6%, p.0.01). Blood transfusions (1.48  0.37 vs. 2.45  0.59, p0.023)
and procedural delays (5 7.47 minutes vs. 22.71  4.98 minutes, p0.01) were more
frequent among patients with major vascular complications (16/17). Finally, mimimum
creatinine clearance after TAVI predicted all-cause 30 days mortality (p0.021).
Conclusions: Major vascular complications after TAVI with the use of Prostar closure
device can be predicted by arterial calcification at the puncture site and TT/AD ratio.
Minimum creatinine clearance after TAVI, predicted 30-day mortality.
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Background: We conducted a meta-analysis to determine whether transradial catheter-
ization is associated with higher patient radiation exposure compared to transfemoral
access.
Methods: Using various keywords, we conducted search at major electronic databases
from 1950 to May 2012.We included original English language articles comparing
transradial and transfemoral access and reporting patient radiation dose in dose area
product and air kerma. Approximate means and standard deviations were obtained by
assuming that data came from a Weibull distribution derived from Monte-Carlo
algorithm.
Results: A total of 14 studies (3 randomized, 10 prospective, 1 retrospective) were
included for analysis. A meta-analysis of all 14 studies revealed no difference in patient
radiation dose between transradial and transfemoral access (standard difference in
mean0.11, 95% CI 0.04 to 0.25, p 0.15).Analysis of the randomized studies alone
also showed no difference (standard difference in mean 0.079, 95% CI0.025 to 0.183,
p0.14). Figure-1 shows the forest plot of combined and the randomized studies. . The
heterogeneity was high (I squared 94) with all studies combined, however the
heterogeneity decreased after removal of the observational studies (I squared37). This
indicates that most of the heterogeneity came from the observational studies likely a result
of biases inherent to non-randomized studies. Begg and Mazumdar’s correlation test
showed no indication of publication bias (two tailed p 0.36).
Conclusions: Transradial catheterization was not associated with higher patient radiation
exposure than transfemoral access.
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Did the RIVAL Trial Increase Transradial Coronary Intervention in Patients
with Acute Myocardial Infarction? Results from Korea Working Group on
Myocardial Infarction Registry
Hye Won Lee1, Jinhee Ahn1, Kwang Soo Cha1, Jeong Cheon Choi1,
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Background: The recent RIVAL trial has made substantial contributions to the world of
percutaneous coronary intervention (PCI), drawing attention to access site and bleeding
complications. However, it is not well known how often the transradial (TR) approach
becomes used after the RIVAL trial in real world clinical practice. We aimed to
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know whether or not the RIVAL trial increased the TR approach for PCI in
patients with acute MI.
Methods: A total of 21,822 patients enrolled for about six years in the Korea Working
Group on Myocardial Infarction Registry were compared between before and after the
publication of the RIVAL trial. Pre-RIVAL group was consisted of 20,155 (96.5%)
patients and post-RIVAL group 767 (3.5%) patients.
Results: Compared to pre-RIVAL group, TR approach was significantly higher in
post-RIVAL group (18.2% vs 23.7%, p0.0001). Procedural success was not different in
pre- and post-RIVAL group (99.0% vs 98.3%) nor was vascular and bleeding complica-
tions (0.21% vs 0.1%). However, compared to TF approach, procedure-related all
complications were significantly lower in TR approach in both pre-RIVAL group (13.3%
vs 5.0%, p0.001) and post-RIVAL group (16.0% vs 4.9%, p0.001). In the subgroup
of ST-segment elevation MI (STEMI), TR approach was significantly higher in post-
RIVAL group (16% vs 22%, p0.001). In the subgroup of elderly patients80 years old,
TR approach was not different in pre- and post-RIVAL group (17.9% vs 13.5%, p0.285)
nor was in the female patients (16.0% vs 19.8%, p0.142).
Conclusions: This study shows that, in the era of post-RIVAL trial, the use of TR





Doppler Control Of Radial Artery After Use of TR Band Following
Coronarography and/or Angioplasty : DRABAND study results
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Background: Radial artery occlusion (RAO) is an infrequent complication of transradial
approach catheterization, but its incidence varies from 1 to 10%. One of predictive factors
is a non patent hemostasis. The purpose of our study was to evaluate radial patency by
Doppler after using a TR Band™ (TERUMO) in real life.
Methods: 574 patients were consecutively included in this european multicentric registry
with 8 centers. All patients received a vasodilator and heparin 	 cocktail 
 and
underwent cardiac catheterization using 5F or 6F introducer sheath and catheters.
Hemostasis was achieved for all patients with a radial compression device (TR Band™),
applied after sheath removal, with the same protocol for set up and removal allowing
flow-limiting compression and a short duration. RAO was evaluated by clinical and
Doppler with and without ulnar compression at 24 hours.
Results: With a majority of right radial approach, coronary angiography was performed
in 62% of cases. 6 Fr was used in 211 patients (37%) and a previous radial approach done
in 25% of cases. Compression pain evaluation on scale was low (2.3 2.4). Any major
site complication was observed, only 11.4% of small hematoma without transfusion or
surgical repair. Radial pulse was clinical patent in 98.5%. Doppler RAO occurred in 3.8%
(n 22). Univariate statistical analysis identified as significant predictors of RAO: no-use
of profile sheath (p  0.001), no pulse after TR Band™ withdrawal (p  0.001) and a
procedure performed by a young radialist physician (p 0.022). RAO was more frequent
with large sheath use and after previous radial approach, but not statistically significant.
Conclusions: Because one the most important RAO predictor factors is the maintain of
radial patency during hemostatic compression, TR Band™ device with its flow-limiting
compression allows to reduce early radial artery occlusion as confirmed by DRABAND
study, with only 3.8% incidence. We have also shown importance of quality sheath choice
avoiding radial occlusion complication.
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Device Deployment In The Transfemoral Transcatheter Aortic Valve
Replacement - A Comparison With Surgical Cut-down
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Background: Surgical cut-down has been a primary approach for arterial access to place
large caliber 22 or 24 Fr sheath used for commercially available transfemoral (TF)
transcatheter aortic valve replacement (TAVR) system in the US. The complete percu-
taneous arterial access and closure was recently introduced as an alternative approach for
arterial access/closure with acceptable safety. However, there has been no study
comparing these two approaches regarding acute clinical outcomes post TF TAVR.
Methods: In 230 patients who underwent TF TAVR using the Edward Sapien heart valve
that requires either 22 Fr or 24 Fr sheath for device deployment, 96 had complete
percutaneous approach using “pre-closure” technique and 134 by surgical cut-down/repair
for arterial access/closure of the device deployment. Immediate success of vascular
access/closure, associated complications and clinical outcome were compared.
Results: Acute success of access and closure was similar between the groups. While
overall access related event was similar, significant stenosis or dissection at the access site
was more frequently observed in the percutaneous group compared to the surgical group
(10.4 % vs. 3.0 %, p  0.020). These were successfully treated with immediate
percutaneous or surgical endovascular intervention. Contrary, compared to the percuta-
neous group, the wound site infection that required either prolonged antibiotics course or
surgical debridement occurred more frequently in the surgical group (1% vs. 6.7%, p 
0.023). While no difference was seen in major vascular complication and bleeding, the
percutaneous group received less frequent transfusion of packed red blood cell less than
or equal to 3 units (30.2 % vs. 43.3% for percutaneous group vs. surgical group, p 
0.044). Median hospital stay was significantly shorter in the percutaneous group (3 days
vs. 4 days for the percutaneous group vs. the surgical group, p  0.008).
Conclusions: Compared to the surgical approach, the complete percutaneous approach
for arterial access/closure of TF TAVR deployment system is feasible with acceptable
safety and potential clinical benefit.
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Major Vascular Complication And Its Management After Complete
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Aortic Valve Replacement
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Suhail Dohad1, Greg Fontana2, Wen Cheng1, Raj Makkar1
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Background: The complete percutaneous access/closure has been introduced as an
alternative approach for surgical cut-down for placement of large caliber sheath in
transfemoral (TF) transcatheter aortic valve replacement (TAVR). However, incidence of
associated major vascular complication (VC), its anatomic characteristics and manage-
ment mode remains uncertain.
Methods: Using the pre-closure technique by deployment of two PerClose Proglide
devices (Abbott Vascular Inc., Santa Clara, California), 118 patients underwent complete
percutaneous approach for placement of either a 22 or 24 Fr sheath for TF TAVR using
the first generation Edwards-Sapien valves (23mm or 26mm diameter). Incidence of
immediate major VC defined by VARC, its angiographic location and success rate of
subsequent endovascular or surgical intervention was assessed.
Results: Major VC occurred in 14.4% of the patients (17 out of 118 cases). Dissection
or perforation of iliac artery was the most common form of the major VA (53%; 9 out of
17). Six cases developed major VC at the puncture site in common femoral artery (one
perforation and 5 stenoses). Two of these cases also had dissection in the separate site
(both at the bifurcation of external and internal iliac artery). All these were successfully
treated with peripheral endovascular intervention. Two other cases required surgical
intervention. One case with ruptured lower abdominal aorta was treated by both
endovascular intervention and surgical repair, and the other that has difficulty of sheath
removal underwent emergent iliofemoral bypass surgery. Compared to the patients
without major VC, the patients with major VC received more frequent blood transfusion
(28% vs. 71%, p 0.0008). However, there was no significant difference in mean length
of hospital stay (4.6  6.9 days vs. 4.8  3.7 days) and 30-day mortality (3.0% vs 5.9%
for no major VC vs. Major VC).
Conclusions: Iliofemoral artery was the most common site of major VC in TF TAVR
with percutaneous access/closure for device access for the first generation Edwards-
Sapien valves.The majority of them can be successfully managed by immediate
endovascular intervention and supportive therapy without affecting acute clinical out-
comes.
TCT-421
Lower periprocedural quality of life in STEMI patients undergoing PCI with
femoral access
Lukasz Koltowski1, Krzysztof Filipiak1, Janusz Kochman1, Grzegorz Opolski1,
Arkadiusz Pietrasik1
1Medical University of Warsaw, Warsaw, Poland
Background: Despite improved clinical outcomes with the transradial access in STEMI,
the data on health related quality of life (HRQoL) is still limited. The aim was to
understand the HRQoL depending on the selected vascular approach.
Methods: 100 STE ACS individuals admitted for PCI were randomized to transfemoral
(TF, n48) or transradial (TR, n52) approach. A EQ-5D, visual analog scale (VAS) and
MacNew instruments were used to assess the HRQoL.
Results: The baseline HRQoL was indifferent (TF vs. TR). Two hours after PCI the
HRQoL improved (VAS: 50,2 vs. 70,1, p0,05). The mobility, self-care and pain were
impaired in the TF vs. TR (p0,01). Over next three days these domains improved and
differences equalized between groups. There was no difference of the total HRQoL on day
three as by VAS (72,1 vs.69,0), EQ-5D and MacNew (5,3 vs. 4,5), despite for lower
scores in emotional domain in the TF vs. TR (4,18 vs. 5,11, p0,05).
Conclusions: The TF approach is associated with lower HRQoL early after PCI and
improves within days after the procedure. An impaired emotional status noticed in TF
group needs to be studied in larger trials. The TR access should be preferred when patients
satisfaction is taken into account.
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